Abstract: An apparatus and method for displaying viewer reactions to a display object. The display object is divided into a plurality of spatial regions, viewer reactions are collected to an exposure to the display object and correlated with the spatial regions, and the display object is displayed with an aspect of the display of each spatial region being a function of the viewer reactions for the region.

Abstract: The Certificate Holder Liability Insurance policy is a new concept in insurance coverage, a new approach to handling the potential coverage problems presented to certificate holders when accepting certificates of insurance from certificate providers and a better means to assure certificate holders that the coverage they require and depend on in insurance policies purchased by others will provide the protection they seek when requiring insurance of third parties.

Abstract: The invention provides an efficient, sensitive, and reliable method for detection of parasites such as Cryptosporidium by efficiently extracting molecular markers or antigens using non-ionic detergents and ECL detection, and kits and compositions for performing such methods.

Abstract: The Headlight Detailer (HLD) is a three part process utilizing specific compounds and procedure for the purpose of detailing automobile headlights and restoring the functionality of the headlight lens. The first part of the process consists of using readily available glass cleaner applied to the headlight lens for initial cleaning. The second step in the process is applying an ammonia and silicone based solution for the purposes of enhanced cleaning and surface preparation. The third and final step in the process includes the application of a wax sealer containing a solution for regenerating the hardened acrylic resin lens surface coating and UV protection.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of celecoxib and/or nimesulide, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with celecoxib and/or nimesulide as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing celecoxib and/or nimesulide in particular formulations, and celecoxib and/or nimesulide with a second compound that also exerts an effect on the androgen receptor.

Abstract: The present invention relates to a troponin protein or complex of two troponin proteins stabilized in a matrix containing at least one anionic surfactant. The stabilized troponin or complex of troponin proteins is used as a control or calibration standard in assays for the determination of blood levels of troponin in patient samples that are expect to exhibit elevated levels of cardiac proteins. The troponin protein or complex of troponin proteins remains stabilized at room temperatures for at least six (6) months.

Abstract: The present invention provides, inter alia, novel methods and compositions for the diagnosis, staging and prognosis of prostate cancer, based on DNA methylation and/or modulation of gene expression, including transcriptional silencing. Preferred diagnostic and/or prognostic nucleic acid and protein markers include at least one of: the differentially (relative to benign tissue) down-regulated sequences corresponding to zinc finger protein 185 (ZNF 185), prostate secretory protein (PSP94), bullous pem-phigoid antigen (BPAG), supervillin (SVIL), proline rich membrane anchor 1 (PRIMA1), TU3A, FLJ14084, KIAA1210, Sorbin and SH3 domain containing 1 (SORBS1), and C21orf63; and the differentially up-regulated sequences MARCKS-like protein (MLP) SRY (sex determining region Y)-box 4 (SOX4), fatty acid binding protein 5 (FABP5), MAL2, and Erg-2.

Abstract: An automated method of and system for collecting and displaying audience recognition information concerning a video presentation, comprising: displaying a video presentation to a plurality of subjects; inquiring of each of the subjects by computer means whether each of a plurality of still images from the video presentation are recognized by each of the subjects; for each of the images, tabulating a percentage of the subjects reporting recognition of the image in inquiring; and automatically generating by computer means a graph comprising each of the images, wherein a position of each of the images on the graph is determined by the corresponding percentage generated in tabulating.

Abstract: A method for the preparation of (CF3)2CHOCH2F (Sevoflurane) is presented, which comprises providing a mixture of (CF3)2CHOCH2Cl, potassium fluoride, water, and a phase transfer catalyst and reacting the mixture to form (CF3)2CHOCH2F.

Abstract: An active guidelines capability or component is linked to a computerized patient record system to integrate the use of clinical guidelines in the workflow of clinicians treating patients. Many healthcare entities maintain sets of clinical guidelines describing recommended treatment or analysis options for patients displaying sets of symptoms or for whom certain diagnoses have been made. The active guidelines feature adds an active guidelines tag to such clinical guidelines so that when the clinician accesses the clinical guidelines and wishes to follow the recommendation, the clinician merely has to click on a hypertext created from the tag which then transmits action orders, also contained in the tag, to be transmitted to the computerized patient record system for implementation. Patient data associated with the recommendations, such as relevant test or lab results, interaction or allergy information, or other current treatments, is also identified and displayed.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of POH, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with POH as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing POH in particular formulations, and POH with a second compound that also exerts an effect on the androgen receptor.

Abstract: A polyurethane in-line roller skate wheel including a narrow hub mounting a polyurethane tire body having side walls curving axially inwardly from a major thickness to a minor thickness at the hub flange interface. In one embodiment, the hub is made of sections locked together by either adhesive or mechanical interlocks.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of quercetin, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with quercetin as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing quercetin in particular formulations, and quercetin with a second compound that also exerts an effect on the androgen receptor.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of omega-3 fatty acids, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with omega-3 fatty acids as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing omega-3 fatty acids in particular formulations, and omega-3 fatty acids with a second compound that also exerts an effect on the androgen receptor.

Abstract: A polyurethane in-line roller skate wheel including a narrow hub mounting a polyurethane tire body having side walls curving axially inwardly from a major thickness to a minor thickness at the hub flange interface. In one embodiment, the hub is made of sections locked together by either adhesive or mechanical interlocks.

Abstract: Techniques using process-pair protection of complex applications are disclosed which provide fast and stateful application failover.

Abstract: A method (110) of manufacturing footprint tiles (10) having the steps of: rolling (112) tile base (12) to a predetermined uniform thickness; imprinting (114) by utilizing a plate or roller with a plurality of convex footprints and exerting pressure upon the rolled tile base (12) forming a plurality of concave footprint impressions (14) into the tile base (12); cutting (116) by utilizing a plate or roller with a plurality of blades complementarity positioned to the plurality of concave footprint impressions (14) and exerting pressure upon the rolled tile base (12) forming individual foot print tiles (10); and drying (120) the individual foot print tiles (10).

Abstract: Modern healthcare enterprises often support complex computer networks for the many functions of the enterprise, and the networks are often running multiple incompatible application programs. Described here is a clinical server exchange device for such a complex network. The clinical exchange server maintains a master table of applications on the network and the patient identification used by each of the applications for each patient. The clinical exchange server can then serve as a sort of interpreter to allow each application to communicate through the clinical exchange server to obtain information from another application about the patient. To facilitate that exchange, each application sends to the clinical exchange server an abstract of any events involving the patient. The clinical exchange server system also envisions a protocol for information exchange, preferably through the clinical exchange server.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of silymarin, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with silymarin as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing silymarin in particular formulations, and silymarin with a second compound that also exerts an effect on the androgen receptor.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of POH, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with POH as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing POH in particular formulations, and POH with a second compound that also exerts an effect on the androgen receptor.